U.S. markets close in 1 hour 45 minutes

MedMira Inc. (MIR.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1250+0.0050 (+4.17%)
As of 11:44AM EDT. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1200
Open0.1250
Bid0.1200 x 0
Ask0.1200 x 0
Day's Range0.1200 - 0.1250
52 Week Range0.1100 - 0.5200
Volume126,177
Avg. Volume421,636
Market Cap82.672M
Beta (5Y Monthly)13.64
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateMar 31, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • MedMira Closes New Equity Investment for Future Growth
      GlobeNewswire

      MedMira Closes New Equity Investment for Future Growth

      HALIFAX, Nova Scotia, July 14, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) has closed a CAD$ 0.5 million equity investment with a Canadian arm’s length investor. The investment is strictly aimed to increase the Company’s growing operational capacity and represents fully diluted less than 1% of the total shareholding. The transaction was approved by the TSX Venture Exchange. Under the terms of deal, the investor will acquire 2,711,496 equity units at $0.18444 per unit. Each

    • MedMira Reports Third Quarter Results FY2021
      GlobeNewswire

      MedMira Reports Third Quarter Results FY2021

      HALIFAX, Nova Scotia, June 29, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2021. Profit and Loss Highlights Revenue: The Company recorded revenues in Q3 FY2021 of $64,631 compared to $87,207 in Q3 FY2020.Gross Profit: The Company recorded a gross profit in Q3 FY2021 of $30,884 compared to $70,344 for the same period last year. The overall gross margin percentage on sales decreased by 33% from 80% in Q2 FY202

    • Performance Update on World Health Organisation SARS-CoV2 Serology Standards
      GlobeNewswire

      Performance Update on World Health Organisation SARS-CoV2 Serology Standards

      HALIFAX, Nova Scotia, June 15, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) announces the World Health Organization (WHO) SARS-CoV-2 serology standards testing results. The REVEALCOVID-19™ PLUS Total Antibody [PLUS] and the REVEALCOVID-19™ Nab-Y Competitive Neutralizing Antibody Test [Nab-Y] have achieved a 100% agreement. On March 29th, 2021, the WHO announced the first International Standards for SARS-CoV-2 serology tests. These WHO standards can serve as the foundation for the